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LETTERS TO THE EDITOR
Exercise Testing in Asymptomatic Patients
After Coronary Artery Bypass Graft Surgery
The recent article by Miller et al. (1) regarding thallium perfusion
imaging in patients having had coronary artery bypass graft (CABG)
surgery 2 years prior was well written and very informative. I agree that
the use of provocative testing after CABG surgery is commonplace but
is done without consensus regarding timing and indication.
Of the 411 patients in Miller’s group, 34% were asymptomatic at
the time of the study and their outcome was included in the whole
group analysis. I would want to know what the results of testing and
outcome were of these asymptomatic patients specifically as I would
expect it to be quite benign so soon following surgery. I also question
the indication for testing in these patients, as the most recent
guidelines from the American Heart Association/American College of
Cardiology task force (a panel that included one author of the present
study) regarding clinical use of radionuclide imaging classifies testing
in asymptomatic patients after CABG surgery as a class III indication
(2).
I have been reluctant to pursue perfusion imaging on post-CABG
surgery patients without the presence of symptoms of cardiac ischemia
or a decline in functional status, especially within the first 5 years of
surgery. If it can be shown that asymptomatic patients do have a
significant prevalence of abnormal studies and poorer outcome, I
would feel obligated to do more routine, surveillance testing.
GREGORY L. MILLER, MD
Grand Rapids Cardiology
1000 East Paris, #215
Grand Rapids, Michigan 49546
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Reply
We appreciate Dr. Miller’s concern about the possibility of inappro-
priately using exercise testing in asymptomatic patients. The American
College of Cardiology/American Heart Association Guidelines for
Clinical Use of Cardiac Radionuclide Imaging (1) do allow some
latitude for testing asymptomatic patients after revascularization pro-
cedures. Although the routine assessment of asymptomatic patients
after percutaneous transluminal coronary angioplasty or coronary
artery bypass graft (CABG) surgery is considered a class III indication,
the use of exercise or pharmacologic perfusion imaging in selected
asymptomatic patients is a class I indication. Because our study cohort
(2) was retrospectively identified using a computer database and these
patients were referred for testing at the discretion of their physicians,
we cannot comment further on the indications for testing in the
patients who were asymptomatic.
In our study the variable “clinical chest pain class” was associated
with the “soft” end point that included late revascularization but was
not significantly associated with the “hard” end points of total mortal-
ity or cardiac death/myocardial infarction (MI), indicating that symp-
tom status was not a major determinant of outcome. Given the
relatively small numbers of hard end points (60 deaths and 53 cardiac
deaths/MIs), one must recognize the shortcomings of performing
subgroup analyses post hoc in view of limited statistical power. Bearing
this limitation in mind, we did separately analyze the subset of 138
asymptomatic patients to address Dr. Miller’s concern. There were 19
deaths, 13 cardiac deaths/MIs and 15 total cardiac events. At 5 years,
overall survival was 88%, survival free of cardiac death/MI 93% and
survival free of cardiac death/MI/late revascularization 90%. The
number of abnormal T1-201 segments on the postexercise image,
which was the most important variable in the total study population,
was not significantly associated with any end point (total mortality, p 5
0.09; cardiac death/MI, p 5 0.30; cardiac death/MI/late revasculariza-
tion, p 5 0.37) in this small number of patients with a limited number
of events.
A recent study (3) from the Cleveland Clinic involving 873
symptom-free patients who underwent exercise T1-201 imaging at a
median of approximately 6 years after CABG surgery reported that
exercise T1-201 variables were predictive of outcome. The authors
concluded that their findings challenged guideline recommendations
against routine testing in this setting. An important limitation of all
studies (2–8) that have been published to date examining the prog-
nostic value of exercise testing after CABG surgery is the use of
selected patient populations. The only approach to accurately address
the issues Dr. Miller raises is to perform a prospective study on a large
series of unselected patients.
TODD D. MILLER, MD
DAVID O. HODGE, MS
RAYMOND J. GIBBONS, MD
Cardiovascular Diseases and Internal Medicine
Mayo Clinic
200 First Street, NW
East 16-A
Rochester, Minnesota 55905
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Interactions Between Infections/Inflammation
and Risk Factors in Coronary Artery Disease
I read with interest the report by Mehta et al. (1) that relates coronary
artery disease, and thus ischemic heart disease (IHD), to interactions
between traditional risk factors and infections and inflammation.
Although Mehta et al. suggested it is unlikely that a common patho-
genetic process can explain atherosclerosis, a hypothesis I recently
proposed, the altered homeostatic (AH) theory (2) provides a unitary
way to explain atherosclerosis and IHD.
The AH theory is based on the spasm of resistance vessel (S-RV)
concept of ischemic diseases (which asserts that S-RV directly induces
symptoms in ischemic diseases as IHD) (3,4), and on a literature
review (5) designed to provide more evidence for the S-RV concept.
The findings of the literature review (5) seemed extraordinary.
Major and diverse risk factors for IHD express the combination of a
tendency toward S-RV and thromboses (S-RV/clotting); risk factors
were abnormal lipids, homocysteine, emotional stress, smoking, circa-
dian rhythm, chemotherapy, cold exposure, cocaine, diabetes and
obesity.
Also, multiple and diverse factors that ameliorate IHD express
vasodilation of resistance vessels (V-RV) and an antithrombotic
tendency (V-RV/anticlotting); ameliorating factors were vasodilators,
fish oils, magnesium, the exercised state, estrogens, aspirin and vita-
mins. Further, the set of risk and ameliorating factors for IHD, with
few exceptions, also operates in hypertension, stroke, migraine and
Raynaud’s disease, and a separate literature review (2) showed that
many of these risk and ameliorating factors are known to operate in
atherosclerosis.
The expression of S-RV/clotting by multiple risk factors for multi-
ple disorders suggested that risk factors might operate through com-
mon mechanisms to induce a variety of diseases, and altered ho-
meostasis seemed a reasonable way to explain these findings. The AH
theory was developed through a series of steps, and important to the
theory’s development was the findings that multiple ameliorating
factors express V-RV/anticlotting and thus act opposite of risk factors
that express S-RV/clotting.
In brief, the AH theory asserts that risk factors favor atheroscle-
rosis, IHD, and other disorders by “inappropriately” shifting ho-
meostasis towards defensive action (fight/flight) and thus favoring
S-RV/clotting and disease; factors that ameliorate IHD shift ho-
meostasis toward rest (conservation/withdrawal) and foster V-RV/
anticlotting and disease improvement. The S-RV/clotting can act
either directly to induce disease or act as markers for other mecha-
nisms of altered homeostasis. Inflammation is a major defense mech-
anism and, in keeping with Mehta et al. (1), probably plays a significant
role in atherosclerosis.
Of interest, the scheme proposed by Mehta et al. (1) for athero-
sclerosis includes multiple factors that were implicated by the AH
theory in altered homeostasis (2). Of special significance to the AH
theory, Mehta et al. listed spasm and thromboses; they also included
inflammation, infection, dyslipidemia, homocysteine excess, folate
deficiency, nitric oxide inactivation and free radicals.
The AH theory, if valid, has major therapeutic implications for
preventing IHD. Instead of the primary goal of cholesterol-lowering,
the primary goal would be reducing the expression of S-RV/clotting by
multiple risk factors; this would include cholesterol-lowering, as cho-
lesterol expresses S-RV/clotting.
H. RICHARD HELLSTROM, MD
Anatomical Pathology
Department of Pathology
College of Medicine
State University of New York
750 Adams Street
Syracuse, NY 13210
E-mail: hellstro@localnet.com
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Reply
I thank Dr. Hellstrom for his comments on our review. I strongly
believe that it is unlikely that a single risk factor or a combination of
four or five risk factors explains a disease process (coronary athero-
sclerosis) that affects a majority of the world population. The proposed
scheme for a role of infection in atherosclerosis in our review was
designed to explain atherogenesis in a select group of genetically
susceptible individuals. Whereas traditional risk factors may explain
the development of atherosclerosis in a significant minority of patients
with coronary artery disease (CAD), in others different factors, such as
homocyteinemia or primary altered homeostasis, may be the culprit. I
believe that the evidence for vasospasm as a primary or major
causative factor in CAD is lacking, although it is quite likely that
vasospasm is a result of altered endothelial and smooth muscle
function secondary to some metabolic or neurohormonal alteration.
An important role for altered activity of autonomic nervous system is
plausible in inducing vasoconstriction (spasm) and in the precipitation
of plaque rupture as a basis of acute coronary syndromes, as suggested
by Hellstrom (his reference 2).
In view of multiple etiologies of coronary atherosclerosis, I suggest
that attempts be made to identify and treat causative factor(s) leading
to atherosclerosis in the individual patient, rather than using a
“shot-gun” approach of use of cholesterol lowering drugs, antiplatelet
and antithrombotic agents, beta-blocking agents and angiotensin-
converting enzyme inhibitors in all patients. Current therapeutic
approaches, including surgical procedures, may represent a “band-aid”
or “patch” approach to treat an underlying problem that may vary from
individual to individual.
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